Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meini

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Pharmacology|May 12, 2000
Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in ratsA Lecci, L A Birder, S Meini, et al.
Biopolymers|March 10, 2001
Structural characterization of lipopeptide agonists for the bradykinin B2 receptorC Giragossian, E Nardi, C Savery, et al.
British Journal of Pharmacology|January 14, 2016
Gender-related differential effect of tachykinin NK2 receptor-mediated visceral hyperalgesia in guinea pig colonF Bellucci, L Buéno, R Bugianesi, et al.
British Journal of Pharmacology|November 27, 2010
Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B₂ receptorS Meini, F Bellucci, C Catalani, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 29, 2012
Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E₂ release and cyclooxygenase 2 expression in human fibroblast-like synoviocytesS Meini, P Cucchi, L Tinti, et al.
Journal of Medicinal Chemistry|February 15, 2001
Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptideP Rovero, M Pellegrini, A Di Fenza, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptorsC A Maggi, M Astolfi, S Giuliani, et al.
European Review for Medical and Pharmacological Sciences|January 5, 2017
Long-term survival of patients with critical limb ischemia treated with iloprost: response rate and predictive criteria. A retrospective analysis of 102 patientsE Melillo, E Lucaccini, R Berchiolli, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptorS Meini, L Quartara, A Rizzi, et al.
Osteoarthritis and Cartilage|August 15, 2013
Synovial fluid levels of bradykinin correlate with biochemical markers for cartilage degradation and inflammation in knee osteoarthritisF Bellucci, S Meini, P Cucchi, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Pharmacology|May 12, 2000
Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in ratsA Lecci, L A Birder, S Meini, et al.
Biopolymers|March 10, 2001
Structural characterization of lipopeptide agonists for the bradykinin B2 receptorC Giragossian, E Nardi, C Savery, et al.
British Journal of Pharmacology|January 14, 2016
Gender-related differential effect of tachykinin NK2 receptor-mediated visceral hyperalgesia in guinea pig colonF Bellucci, L Buéno, R Bugianesi, et al.
British Journal of Pharmacology|November 27, 2010
Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B₂ receptorS Meini, F Bellucci, C Catalani, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 29, 2012
Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E₂ release and cyclooxygenase 2 expression in human fibroblast-like synoviocytesS Meini, P Cucchi, L Tinti, et al.
Journal of Medicinal Chemistry|February 15, 2001
Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptideP Rovero, M Pellegrini, A Di Fenza, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptorsC A Maggi, M Astolfi, S Giuliani, et al.
European Review for Medical and Pharmacological Sciences|January 5, 2017
Long-term survival of patients with critical limb ischemia treated with iloprost: response rate and predictive criteria. A retrospective analysis of 102 patientsE Melillo, E Lucaccini, R Berchiolli, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptorS Meini, L Quartara, A Rizzi, et al.
Osteoarthritis and Cartilage|August 15, 2013
Synovial fluid levels of bradykinin correlate with biochemical markers for cartilage degradation and inflammation in knee osteoarthritisF Bellucci, S Meini, P Cucchi, et al.
Pageof 7